Catalyst Wire Dossier Catalyst Wire Dossier

Myval Transcatheter Heart Valve Series

· Meril Life Sciences Pvt. Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Myval Transcatheter Heart Valve Series, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate Safety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series Compared toGuideline-Directed Medical Therapy (GDMT) in Participants With Moderate Aortic Stenosis. [NA]

See pricing